Los Angeles, USA, May 13, 2021 (GLOBE NEWSWIRE) -- Netherton Syndrome Pipeline: Industry Insights into Global emerging therapies scenario, Leading Pharma Players, Emerging Trends | DelveInsight ...
Quoin Pharmaceuticals has made impressive progress in its two ongoing Netherton Syndrome clinical trials. The company's open-label study reached the 50% recruitment mark in just a few months and the ...
Multi-pronged media campaign to raise awareness about the disease and its impact on patients, family members and caregivers. Interactive, stand-alone NETHERTON NOW website launched. Quoin's QRX003 ...
ASHBURN, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- In recognition of Rare Disease Day® 2026, Quoin Pharmaceuticals Ltd. (QNRX) today highlighted the continued growth of its NETHERTON NOW awareness ...